ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 151 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $4,357,000 | -15.3% | 51,641 | -4.1% | 0.01% | -15.4% |
Q1 2019 | $5,143,000 | +30.3% | 53,845 | -3.3% | 0.01% | +18.2% |
Q4 2018 | $3,946,000 | +9.2% | 55,705 | +31.7% | 0.01% | +22.2% |
Q3 2018 | $3,615,000 | -16.4% | 42,299 | +13.4% | 0.01% | -18.2% |
Q2 2018 | $4,322,000 | +45.7% | 37,289 | +1.7% | 0.01% | +37.5% |
Q1 2018 | $2,966,000 | +46.8% | 36,654 | +6.4% | 0.01% | +33.3% |
Q4 2017 | $2,021,000 | +27.7% | 34,446 | +1.9% | 0.01% | +20.0% |
Q3 2017 | $1,582,000 | -8.0% | 33,800 | -29.3% | 0.01% | 0.0% |
Q2 2017 | $1,720,000 | +16.8% | 47,800 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $1,472,000 | -14.2% | 47,800 | -6.6% | 0.01% | -16.7% |
Q4 2016 | $1,715,000 | +25.9% | 51,200 | 0.0% | 0.01% | +20.0% |
Q3 2016 | $1,362,000 | +4.7% | 51,200 | -13.2% | 0.01% | 0.0% |
Q2 2016 | $1,301,000 | -24.1% | 58,990 | +1.1% | 0.01% | -16.7% |
Q1 2016 | $1,714,000 | -11.1% | 58,360 | 0.0% | 0.01% | -14.3% |
Q4 2015 | $1,927,000 | +8.8% | 58,360 | +19.1% | 0.01% | 0.0% |
Q3 2015 | $1,771,000 | -31.8% | 49,000 | -15.1% | 0.01% | -22.2% |
Q2 2015 | $2,596,000 | – | 57,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |